Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747604 · ClinicalTrials.gov registry record
IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex
A clinical trial, sponsored by Ipsen.
- Terminated
- Registry status
- 1,378
- Enrollment target
NCT00747604: Clinical Trial study, sponsored by Ipsen.
NCT00747604 is a clinical trial that was terminated before completion, run by Ipsen. The registered enrollment target is 1,378 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747604 was terminated before completion, sponsored by Ipsen.
- TERMINATED
- Registry status
- 1,378 participants
- Enrollment target
Study Summary
This project is a retrospective (beginning January 2006) and prospective patient registry program sponsored by Ipsen (formerly Tercica, Inc.). In collaboration with participating health care practitioners, the patient registry program is an observational study monitoring the long-term safety of patients treated with Increlex® (mecasermin \[rDNA origin\] injection). The IGFD (Increlex® Growth Forum Database) Registry is intended primarily to monitor the safety and efficacy of Increlex replacement therapy in children with growth failure.
Interventions
- BIOLOGICAL mecasermin [rDNA origin] injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,378 participants |
| Start Date | 2006-06 |
| Est. Completion | 2014-05 |
Why NCT00747604 stopped before completion
NCT00747604 is an observational study that tracks outcomes without assigning an intervention. Its 1,378 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which mecasermin [rDNA origin] injection is the first listed.
NCT00747604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00747604 about?
NCT00747604 is a clinical study titled "IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex". This project is a retrospective (beginning January 2006) and prospective patient registry program sponsored by Ipsen (formerly Tercica, Inc.). In collaboration with participating health care practitioners, the patient registry program is an observational study monitoring the long-term safety of pati...
What is the current status of trial NCT00747604?
This trial is currently terminated. The enrollment target is 1,378 participants. The study started on 2006-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00747604?
The interventions under investigation include: mecasermin [rDNA origin] injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT00747604?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia